Pomanda estimates the enterprise value of BEAGLE TREATMENTS LIMITED at £0 based on a Turnover of £0 and 0.67x industry multiple (adjusted for size and gross margin).
beagle treatments limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BEAGLE TREATMENTS LIMITED at £0 based on an EBITDA of £0 and a 4.5x industry multiple (adjusted for size and gross margin).
beagle treatments limitedEstimated Valuation
£2
Pomanda estimates the enterprise value of BEAGLE TREATMENTS LIMITED at £2 based on Net Assets of £1 and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Beagle Treatments LimitedOverview
Beagle Treatments Limited is a live company located in dorset, BH23 1EX with a Companies House number of 07690572. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in July 2011, it's largest shareholder is
beagle technology group limited
with a 100% stake. Beagle Treatments Limited is a established,
unknown sized company, Pomanda has estimated its turnover at
£0 with
unknown
growth in recent years.
There is insufficient data available to calculate a health check for Beagle Treatments Limited. Company Health Check FAQs
Health Rating0out of 5
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Beagle Treatments Limited
- - Industry AVG
BEAGLE TREATMENTS LIMITED financials
EXPORT
Beagle Treatments Limited's latest turnover from December 2024 is estimated at 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Beagle Treatments Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Jan 2014
Jul 2012
Turnover
Other Income Or Grants
Cost Of Sales
Gross Profit
Admin Expenses
Operating Profit
Interest Payable
Interest Receivable
Pre-Tax Profit
Tax
Profit After Tax
Dividends Paid
Retained Profit
Employee Costs
Number Of Employees
EBITDA*
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Jan 2014
Jul 2012
Tangible Assets
Intangible Assets
Investments & Other
1
1
1
1
1
1
Debtors (Due After 1 year)
Total Fixed Assets
1
1
1
1
1
1
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors
Cash
misc current assets
total current assets
total assets
1
1
1
1
1
1
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
net assets
1
1
1
1
1
1
total shareholders funds
1
1
1
1
1
1
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Jan 2016
Jan 2015
Jan 2014
Jul 2012
Operating Activities
Operating Profit
Depreciation
Amortisation
Tax
Stock
Debtors
Creditors
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
Investing Activities
capital expenditure
Change in Investments
1
1
cash flow from investments
-1
-1
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1
1
interest
cash flow from financing
1
1
cash and cash equivalents
cash
overdraft
change in cash
beagle treatments limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for beagle treatments limited. Get real-time insights into beagle treatments limited's credit score, group structure and payment trends.
Perform a competitor analysis for beagle treatments limited by selecting its closest rivals, whether from the MANUFACTURING sector, other established companies, companies in BH23 area or any other competitors across 12 key performance metrics.
beagle treatments limited Ownership
BEAGLE TREATMENTS LIMITED group structure
Beagle Treatments Limited has no subsidiary companies.
The sole shareholder of Beagle Treatments Limited is Beagle Technology Group Limited.
beagle technology group limited
100%
beagle treatments limited directors
Beagle Treatments Limited currently has 2 directors.
The longest serving directors include
Mr Michael Welden (Dec 2018) and
Mr Ronald Robinson (Mar 2024).
stony lane christchurch, christchurch, dorset, BH23 1EX
Bank
-
Legal Advisor
-
beagle treatments limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to beagle treatments limited.
beagle treatments limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BEAGLE TREATMENTS LIMITED. This can take several minutes, an email will notify you when this has completed.
beagle treatments limitedCompanies House Filings - See Documents
